Rockefeller Capital Management
EDIT icon

Rockefeller Capital Management’s Editas Medicine EDIT Stock Holding History

Rockefeller Capital Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$72.8K Sell
22,465
-575
-2% -$1.68K ﹤0.01% 3162
2026
Q1 		$56.9K Buy
23,040
+78
+0.3% +$165 ﹤0.01% 3203
2025
Q4 		$47.1K Buy
22,962
+425
+2% +$1.23K ﹤0.01% 3099
2025
Q3 		$78.2K Buy
+22,537
New +$62.9K ﹤0.01% 2699
2023
Q3 		– Sell
-18,533
Closed -$153K – 1573
2023
Q2 		$153K Buy
18,533
+379
+2% +$3.3K ﹤0.01% 1712
2023
Q1 		$131K Buy
18,154
+1,000
+6% +$8.89K ﹤0.01% 1872
2022
Q4 		$152K Sell
17,154
-1,765
-9% -$19.4K ﹤0.01% 1802
2022
Q3 		$231K Buy
18,919
+40
+0.2% +$623 ﹤0.01% 1586
2022
Q2 		$223K Buy
18,879
+2,243
+13% +$30.1K ﹤0.01% 1592
2022
Q1 		$316K Buy
16,636
+15,003
+919% +$279K ﹤0.01% 1501
2021
Q4 		$43K Sell
1,633
-6,260
-79% -$215K ﹤0.01% 2278
2021
Q3 		$323K Buy
7,893
+5,379
+214% +$295K ﹤0.01% 1413
2021
Q2 		$142K Buy
2,514
+465
+23% +$17.2K ﹤0.01% 1654
2021
Q1 		$86K Buy
2,049
+1,018
+99% +$58K ﹤0.01% 1672
2020
Q4 		$72K Buy
1,031
+467
+83% +$19.2K ﹤0.01% 1559
2020
Q3 		$15K Buy
+564
New +$18.4K ﹤0.01% 1880
2020
Q1 		– Sell
-7
Closed – – 2379
2019
Q4 		$0 Buy
+7
New +$175 ﹤0.01% 2083

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Rockefeller Capital Management's EDIT Position: Q2 2026 in Review

Rockefeller Capital Management reduced its Editas Medicine (EDIT) stake by 2.5% in Q2 2026, selling an estimated $1.68K and leaving 22,465 shares worth $72.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3162.

Rockefeller Capital Management first reported a position in EDIT in Q4 2019 and has held it in 17 quarters since. The position peaked at $323K in Q3 2021. 215 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Rockefeller Capital Management held 22,465 shares of Editas Medicine worth $72.8K as of Q2 2026.
  • Rockefeller Capital Management sold 575 Editas Medicine shares in Q2 2026, an estimated $1.68K.
  • Editas Medicine made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #3162 holding.
  • Rockefeller Capital Management first reported a position in Editas Medicine in Q4 2019 and has held it in 17 quarters since.
  • Rockefeller Capital Management's Editas Medicine position peaked at $323K in Q3 2021.
  • 215 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.